FDC wins MHRA UK approval for Atropine eye drops.

FDC wins MHRA UK approval for Atropine eye drops. This clears the way for market entry of Atropine 1.0% w/v Eye Drops, Solution in the UK. Regulatory approval supports future revenue potential in ophthalmic segment. The development reflects progress in FDC’s product rollout strategy.

📊 STOCKS: $FDC | 🏢 SECTOR: Pharma | #LOWIMPACT #Regulatory